Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2025-12-28 @ 6:49 AM
Study NCT ID:
NCT06959095
Status:
RECRUITING
Last Update Posted:
2025-10-08
First Post:
2025-04-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2029-08-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08-20
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-28
First Submit QC Date:
None
Study First Post Date:
2025-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-06
Last Update Post Date:
2025-10-08
Last Update Post Date Type:
ESTIMATED